N 0840

Known as: N-0840 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2006
0119932006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Initial mutagenesis studies exploring the ligand recognition model of A1 adenosine receptor (A1R) mainly focused on the residues… (More)
Is this relevant?
2004
2004
Novel 3,8- and 8,9-disubstituted N(6)-cyclopentyladenine derivatives were synthesised in moderate overall yield from 6… (More)
Is this relevant?
2003
2003
At nanomolar concentrations, SR141716 and AM251 act as specific and selective antagonists of the cannabinoid CB1 receptor. In the… (More)
Is this relevant?
2002
2002
This report describes the precursor synthesis and the no-carrier-added (nca) radiosynthesis of the new A(1) adenosine receptor (A… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
1999
1999
The purpose of this investigation was to test the hypothesis that A(1) receptors modulate extracellular levels of adenosine in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
1998
1998
Receptor antagonists can be classified as neutral antagonists or antagonists with inverse agonist activity based on their… (More)
Is this relevant?
1993
1993
The pharmacological and biochemical profile of N6-cyclopentyl-9-methyladenine (N-0840) was elucidated in vitro and in vivo. In… (More)
Is this relevant?